Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Wang, H; Zhang, YT; Huang, BY; Deng, W; Quan, YR; Wang, WL; Xu, WB; Zhao, YX; Li, N; Zhang, J; Liang, HY; Bao, LL; Xu, YF; Ding, L; Zhou, WM; Gao, H; Liu, JN; Niu, PH; Zhao, L; Zhen, W; Fu, H; Yu, SZ; Zhang, ZL; Xu, GX; Li, CG; Lou, ZY; Xu, M; Qin, C; Wu, GZ; Gao, GF; Tan, WJ; Yang, XM

Yang, XM (corresponding author), Beijing Inst Biol Prod Co Ltd, Beijing, Peoples R China.; Wu, GZ; Gao, GF; Tan, WJ (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.; Qin, C (corresponding author), Chinese Acad Med Sci, NHC Key Lab Human Dis Comparat Med, Natl Anim Models Human Dis Resources Ctr, Inst Lab Anim Sci,Beijing Key Lab Anim Models Eme, Beijing, Peoples R China.; Qin, C (corresponding author), Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China.; Li, CG; Xu, M (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.; Lou, ZY (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Sch Med, Beijing, Peoples R China.; Lou, ZY (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Sch Med, Beijing, Peoples R China.

CELL, 2020; 182 (3): 713